ABBOTT LABORATORIES (ABT) Income statement

Top 20 of 28 line items reported by ABT · 250+ in the full API →

ABBOTT LABORATORIES (ABT) · Income Statement

Consolidated Statements of Operations

Quarterly · In millions USD, except per-share data · Latest filed Nov 4, 2026 · FY ends Dec 31

Three Months Ended
Q3 2026
Sep 30, 2026
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Trend
Total Revenue$13,013$12,593$11,164$11,459$11,369
Cost of Revenue5,6285,3254,8904,9225,075
Gross Profit$7,385$7,268$6,274$6,537$6,294
Other Operating Expenses6,0275,5754,9294,2864,237
Total Operating Expenses11,65510,9009,8199,2089,312
Operating Income$1,358$1,693$1,345$2,251$2,057
EBIT (Earnings Before Interest & Tax)1,3581,6931,3452,2512,057
Add: Depreciation & Amortization1,2561,060803792791
EBITDA (Non-GAAP)$2,614$2,753$2,148$3,043$2,848
Interest Income53521067877
Interest Expense-350-351-174-120-121
Foreign Exchange Gain (Loss)6(4)131517
Non-Operating Income (Expense)$(291)$(303)$(55)$(27)$(27)
Income Before Taxes (EBT)$1,231$1,524$1,449$2,358$2,180
Provision for Income Taxes311596372582536
Effective Tax Rate25.3%39.1%25.7%24.7%24.6%
Net Income$920$928$1,077$1,776$1,644
Shares Outstanding1,7341,7401,7421,7391,742
Diluted Earnings Per Share$0.53$0.53$0.61$1.03$0.94
Gross Margin56.8%57.7%56.2%57%55.4%
8 more line items available via the API
Research & DevelopmentSales, General & AdministrativeAsset Impairment ChargesDiluted Shares OutstandingBasic Earnings Per ShareOperating MarginOther OpEx MarginNet Margin
Ask your agent:get_financialsAPIGET /api/v1/companies/ABT/income-statement?period=quarterly&years=2Docs →